สำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์

Printed on 10 January 2026 15:20

Publication Document

Please enter search criteria
Document Type
Issuer / Underlying / Securities
Date From
To

JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED : JSP

The Financial Statements which need to be revised ( 0 record(s) found)
Order DateCompany NameReviewed Financial Statement Details
Data not found
Finanacial Statements ( 32 record(s) found)
NameYearStatusTypePeriodAs OfDetails
JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED2025ReviewedConsolidatedQ330/09/2025
JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED2025ReviewedCompanyQ330/09/2025
JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED2025ReviewedConsolidatedQ230/06/2025
JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED2025ReviewedCompanyQ230/06/2025
JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED2025ReviewedConsolidatedQ131/03/2025
JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED2025ReviewedCompanyQ131/03/2025
JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED2024AuditedConsolidatedYear31/12/2024
JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED2024AuditedCompanyYear31/12/2024
JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED2024ReviewedConsolidatedQ330/09/2024
JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED2024ReviewedCompanyQ330/09/2024
Key Financial Ratio ( 0 record(s) found)
NameBusiness TypeTypePeriodYearAs OfDetails
Data not found
Management's Discussion and Analysis ( 13 record(s) found)
DateTimeHeadingLink
14/11/202419:12Management Discussion and Analysis Quarter 3 Ending 30 Sep 2024
13/08/202418:43Management Discussion and Analysis Quarter 2 Ending 30 Jun 2024
15/05/202418:31Management Discussion and Analysis Quarter 1 Ending 31 Mar 2024
28/02/202418:52Management Discussion and Analysis Yearly Ending 31 Dec 2023
14/11/202318:47Management Discussion and Analysis Quarter 3 Ending 30 Sep 2023
15/08/202318:52Management Discussion and Analysis Quarter 2 Ending 30 Jun 2023
15/05/202319:26Management Discussion and Analysis Quarter 1 Ending 31 Mar 2023
24/02/202320:02Management Discussion and Analysis Yearly Ending 31 Dec 2022
15/11/202212:41Management Discussion and Analysis Quarter 3 Ending 30 Sep 2022
14/11/202218:37Management Discussion and Analysis Quarter 3 Ending 30 Sep 2022
SEC has ordered to amend Finanacial Statements ( 0 record(s) found)
NameDescriptionDetails
Data not found

Last updated on 09 January 2026